ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

NCI-Approved Clinical Trials

February 23, 2007

NCAB, DRCCA Board Asked To Consider Dripping All Staff Investigator Salary Support From Core

October 17, 1980